promising Archives - Family Medicine News

Promising findings for treating damaged heart valves

13.12.2019 Health Problems

Aortic valve calcification is a challenging condition for the health service and for the patients concerned. The only treatment currently available is surgery. Mariia Boganova recently defended her thesis which addresses the options available for future pharmacological treatment. Mechanisms behind the disease The Russian doctoral research fellow explains that her thesis first looks at the mechanisms behind the disease. She […]

Novel regulator of mitochondrial cell death reveals a promising target for cancer therapy

20.09.2019 Health Problems

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types. These results were published online in […]

Diattenuation imaging—a promising imaging technique for brain research

20.03.2019 Health Problems

A new imaging method provides structural information about brain tissue that was previously difficult to access. Diattenuation Imaging (DI), developed by scientists at Forschungszentrum Jülich and the University of Groningen, allows researchers to differentiate regions with many thin nerve fibres from regions with few thick nerve fibres. With current imaging methods, these tissue types cannot easily be distinguished. The DI […]

Game over for Zika? Researchers develop promising vaccine

20.12.2018 Health Problems

Scientists at the KU Leuven Rega Institute in Belgium have developed a new vaccine against the Zika virus. This vaccine should prevent the virus from causing microcephaly and other serious conditions in unborn babies. In 2015 and 2016, the world was shocked by the sudden and massive outbreak of the Zika virus in Latin America. “The Zika virus is transmitted […]

First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple

15.04.2018 Health Problems

A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary […]